Ascus Biosciences, Inc.
USPTO PatentsView assignee record - 12 granted patents across 11 technology areas, recorded in grant years 2017–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A23K (Fodder).
The verdict
According to USPTO PatentsView, Ascus ranks #22,211 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 11 technology areas.
- #22,211
- of 49,997 US assignees by volume
- 40th percentile
- by Innovation Score (32.2/100)
- 19.3
- avg claims per patent
- -29%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R22211 · US Corporation #22,211 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 12 grants
- MID-PACK #22,211/49,997
- PHOTO-FINISH Areva Wind
- CPC-FOCUS A23K · 11 areas
- INNOV-THIN 32.2/100
- CLAIMS-RICH 19.3 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -29% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Areva Wind GmbH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ascus’s 32.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ascus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ascus Biosciences · this assignee 32
Ascus Biosciences · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ascus's Innovation Score is 32.2/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ascus?
Each dot is one of Ascus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ascus’s own 19.3 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Ascus's grants concentrate
Ascus Biosciences, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A23K (Fodder). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2017. By volume, Ascus sits between Areva Wind GmbH and Atlas Genetics Limited.
Who files at Ascus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Areva Wind
Areva Wind GmbH
12 patents
- Arntz Beteiligung…
Arntz Beteiligungs GmbH & Co. KG
12 patents
- Arrows Up
Arrows Up, LLC
12 patents
- Artema Labs
Artema Labs, Inc
12 patents
- Aspiring Sky
Aspiring Sky Co. Limited
12 patents
- Astra Capital Inc…
Astra Capital Incorporated
12 patents
- Astrumu
AstrumU, Inc.
12 patents
- Atlas Genetics
Atlas Genetics Limited
12 patents
- Ascus Biosciences ◀
Ascus Biosciences, Inc.
12 patents
What this shows Ascus holds 12 patents at rank #22,225, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ascus
By rank, the assignees closest to #22,225 in granted patent volume.
- Areva Wind GmbH #22,221 · 12 patents
- Arntz Beteiligungs GmbH & Co. KG #22,222 · 12 patents
- Arrows Up, LLC #22,223 · 12 patents
- Artema Labs, Inc #22,224 · 12 patents
- Aspiring Sky Co. Limited #22,226 · 12 patents
- Astra Capital Incorporated #22,227 · 12 patents
- AstrumU, Inc. #22,228 · 12 patents
- Atlas Genetics Limited #22,229 · 12 patents
Leaders in A23K (Fodder)
Other assignees with the most granted patents in Ascus's primary technology class.
Ascus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 40th percentile higher than 40% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 8.3% |
| 2018 | 2 | 16.7% |
| 2019 | 4 | 33.3% |
| 2020 | 5 | 41.7% |
Which technologies does Ascus Biosciences, Inc. patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ascus Biosciences, Inc.'s patent record in context - here's where to go next.
- Ascus Biosciences, Inc.'s lead technology class is A23K (Fodder), 100% of its portfolio - see every assignee active in that class. Explore A23K
- Ranked #22,211 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ascus Biosciences, Inc. against Areva Wind GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.